Autoreactive CD8+ T-cells are highly dependent on CD8 for activation and as such targeting CD8 is an effective way of blocking autoreactive CD8+ T-cell activation

Linda Wooldridge(University of Bristol), Matthew Clement(Cardiff University), Julia Ekeruche-Makinde(Cardiff University), Sian Llewellyn‐Lacey(University College London Hospitals NHS Foundation Trust), Hugo A. van den Berg(University of Warwick), James E. McLaren(Cardiff University), Scott R. Burrows(Australian National University), Emma Gostick(University Hospital of Wales), Mark Peakman(Sanofi (France)), Tamsin Dockree(Cardiff University), Jamie Rossjohn(Institute of Infection and Immunity), Stéphanie Gras(La Trobe University), James A. Pearson(Institute of Infection and Immunity), Neil P. Robertson(Cardiff University), David A. Price(University Hospital of Wales), D.A.L. Morgan(Nottingham University Hospitals NHS Trust), Mark Willis(Flinders University), Anya Lissina(University of Bristol), Ania Skowera(National Health Service), Susan J. Wong(University of Wales Institute Cardiff)
The Journal of Immunology
May 1, 2017
Cited by 0


Related Papers